Login
$CEVA
$31.35 +$1.94 (6.6%) Live

Interim Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Short-term bank deposits
Marketable securities
Trade receivables (net of allowance for credit losses of $288 at both June 30, 2026 and December 31, 2025)
Prepaid expenses and other current assets
Current assets of discontinued operation
Total current assets
Long-term assets:
Bank deposits
Severance pay fund
Deferred tax assets, net
Property and equipment, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net
Investments in marketable equity securities
Other long-term assets
Long-term assets of discontinued operation
Total long-term assets
Total assets
Current liabilities:
Trade payables
Deferred revenues
Accrued expenses and other payables
Accrued payroll and related benefits
Operating lease liabilities
Current liabilities of discontinued operation
Total current liabilities
Long-term liabilities:
Accrued severance pay
Operating lease liabilities
Other accrued liabilities
Total long-term liabilities of discontinued operations
Total long-term liabilities
Stockholders’ equity:
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; none issued and outstanding
Common Stock, $0.001 par value; 45,000,000 shares authorized; 28,137,917 and 27,583,325 shares issued at June 30, 2026 and December 31, 2025, respectively; 28,137,917 and 27,510,739 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid in-capital
Treasury stock at cost (0 and 72,586 shares of common stock at June 30, 2026 and December 31, 2025, respectively)
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support